CME Group Statistics

Total Valuation

CME Group has a market cap or net worth of EUR 87.08 billion. The enterprise value is 88.13 billion.

Market Cap	87.08B
Enterprise Value	88.13B

Important Dates

The last earnings date was Wednesday, April 22, 2026.

Earnings Date	Apr 22, 2026
Ex-Dividend Date	Mar 10, 2026

Share Statistics

Current Share Class	362.36M
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.83%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	91.32%
Float	360.74M

Valuation Ratios

The trailing PE ratio is 23.65 and the forward PE ratio is 23.12.

PE Ratio	23.65
Forward PE	23.12
PS Ratio	14.89
PB Ratio	3.77
P/TBV Ratio	n/a
P/FCF Ratio	23.19
P/OCF Ratio	22.71
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.86, with an EV/FCF ratio of 23.47.

EV / Earnings	23.94
EV / Sales	15.33
EV / EBITDA	19.86
EV / EBIT	21.33
EV / FCF	23.47

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.14.

Current Ratio	1.02
Quick Ratio	0.02
Debt / Equity	0.14
Debt / EBITDA	0.78
Debt / FCF	0.86
Interest Coverage	25.45

Financial Efficiency

Return on equity (ROE) is 15.92% and return on invested capital (ROIC) is 12.20%.

Return on Equity (ROE)	15.92%
Return on Assets (ROA)	1.55%
Return on Invested Capital (ROIC)	12.20%
Return on Capital Employed (ROCE)	12.39%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.51M
Profits Per Employee	950,068
Employee Count	3,875
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, CME Group has paid 1.15 billion in taxes.

Income Tax	1.15B
Effective Tax Rate	23.70%

Stock Price Statistics

The stock price has increased by +3.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+3.90%
50-Day Moving Average	259.76
200-Day Moving Average	240.81
Relative Strength Index (RSI)	35.94
Average Volume (20 Days)	17

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.02

Income Statement

In the last 12 months, CME Group had revenue of EUR 5.85 billion and earned 3.68 billion in profits. Earnings per share was 10.16.

Revenue	5.85B
Gross Profit	5.85B
Operating Income	3.87B
Pretax Income	4.85B
Net Income	3.68B
EBITDA	4.16B
EBIT	3.87B
Earnings Per Share (EPS)	10.16

Balance Sheet

The company has 2.18 billion in cash and 3.25 billion in debt, giving a net cash position of -1.06 billion.

Cash & Cash Equivalents	2.18B
Total Debt	3.25B
Net Cash	-1.06B
Net Cash Per Share	n/a
Equity (Book Value)	23.09B
Book Value Per Share	63.81
Working Capital	2.60B

Cash Flow

In the last 12 months, operating cash flow was 3.83 billion and capital expenditures -79.01 million, giving a free cash flow of 3.75 billion.

Operating Cash Flow	3.83B
Capital Expenditures	-79.01M
Depreciation & Amortization	283.22M
Net Borrowing	-1.45M
Free Cash Flow	3.75B
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 66.15% and 63.32%.

Gross Margin	100.00%
Operating Margin	66.15%
Pretax Margin	82.99%
Profit Margin	63.32%
EBITDA Margin	71.07%
EBIT Margin	66.15%
FCF Margin	64.20%

Dividends & Yields

This stock pays an annual dividend of 9.65, which amounts to a dividend yield of 3.98%.

Dividend Per Share	9.65
Dividend Yield	3.98%
Dividend Growth (YoY)	-2.55%
Years of Dividend Growth	n/a
Payout Ratio	95.15%
Buyback Yield	-0.28%
Shareholder Yield	3.70%
Earnings Yield	4.23%
FCF Yield	4.31%

Dividend Details

Stock Splits

The last stock split was on July 23, 2012. It was a forward split with a ratio of 5.

Last Split Date	Jul 23, 2012
Split Type	Forward
Split Ratio	5

Scores

CME Group has an Altman Z-Score of 0.5 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.5
Piotroski F-Score	5